Data provided by Nasdaq. Minimum 15 minutes delayed.
October 31, 2018
Nuvectra® to Participate in Two Upcoming Investor Conferences
PLANO, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to participate in two upcoming investor conferences. Event: 2018 Stephens NY Investment Conference Date: Tuesday, November 6, 2018 Time: 9:00 a.m. E
October 29, 2018
Nuvectra® Reports Third Quarter 2018 Financial Results
Reports Record Algovita® Sales of $12.5 million, Up 98% YoY PLANO, Texas, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the third quarter ended September 30, 2018. Highlights Record consolidated revenues of $14.2 million, up 87% YoY Consolidated gross margin increased to 54%, up from 46% in the third quarter of 2017 Completed secondary offering with net proceeds of $64.6 milli
The Ruth Group